Cargando…
Red Blood Cell BCL-x(L) Is Required for Plasmodium falciparum Survival: Insights into Host-Directed Malaria Therapies
The development of antimalarial drug resistance is an ongoing problem threatening progress towards the elimination of malaria, and antimalarial treatments are urgently needed for drug-resistant malaria infections. Host-directed therapies (HDT) represent an attractive strategy for the development of...
Autores principales: | Boulet, Coralie, Siddiqui, Ghizal, Gaynor, Taylah L., Doerig, Christian, Creek, Darren J., Carvalho, Teresa G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027239/ https://www.ncbi.nlm.nih.gov/pubmed/35456874 http://dx.doi.org/10.3390/microorganisms10040824 |
Ejemplares similares
-
A new mass spectral library for high-coverage and reproducible analysis of the Plasmodium falciparum–infected red blood cell proteome
por: Siddiqui, Ghizal, et al.
Publicado: (2022) -
Eryptosis and Malaria: New Experimental Guidelines and Re-Evaluation of the Antimalarial Potential of Eryptosis Inducers
por: Boulet, Coralie, et al.
Publicado: (2021) -
Peroxide Antimalarial Drugs Target Redox Homeostasis
in Plasmodium falciparum Infected Red
Blood Cells
por: Siddiqui, Ghizal, et al.
Publicado: (2022) -
System-wide biochemical analysis reveals ozonide antimalarials initially act by disrupting Plasmodium falciparum haemoglobin digestion
por: Giannangelo, Carlo, et al.
Publicado: (2020) -
The protein-phosphatome of the human malaria parasite Plasmodium falciparum
por: Wilkes, Jonathan M, et al.
Publicado: (2008)